logo

In The Spotlight

Share

ipo oct29 The number of healthcare firms that have gone public on the U.S. stock exchanges so far this month is 17. Let's take a look at the IPOs scheduled for Friday (Oct 30).

ipo oct27 In the healthcare sector, 17 companies have made their debut on the NASDAQ so far this month. Let's take a look at the U.S. healthcare IPOs scheduled for the week.

foghorntherapeutics oct22 Foghorn Therapeutics, founded in 2015, is a pre-clinical stage biotechnology company developing drugs that target the *chromatin regulatory system for a wide range of cancers through its proprietary Gene Traffic Control Product Platform. *The chromatin regulatory system is a system that orchestrates the movement of molecules that turn genes "on" and "off."

calliditas oct19 Shares of Calliditas Therapeutics AB (CALT) have gained nearly 21% so far this month, as the company gears up for a clinical trial catalyst this quarter.

ipo 1014 The number of healthcare firms that have gone public on the U.S. stock exchanges so far this month is 9. Let's take a look at the IPOs scheduled for tomorrow.

ipo oct13 There have been 8 IPOs in the healthcare sector so far this month in the U.S. stock market. Listed below are the healthcare companies that are going public this week.

personalis oct12 Shares of Personalis Inc. (PSNL) closed at an all-time high of $30.52 on Friday (Oct.9, 2020) and that reflects a gain of over 140 percent in 3.5 months after our stock alert.

ipo oct07 We are just days into the final quarter of the year. The number of healthcare firms that have gone public on the U.S. stock exchanges so far this month is 4. Let's take alook at the IPOs scheduled for Friday (Oct 9).

aziyo oct05 Silver Spring, Maryland-based Aziyo Biologics is scheduled to go public on the Nasdaq Global Select Market under the symbol "AZYO" on October 8, 2020.

ipo sept30 The IPO activity in the U.S. pharma/biotech sector has had a strong showing so far this year, with 69 listings compared to only 46 during the same period last year. In the third quarter, 34 companies belonging to the healthcare sector were listed on the major stock exchanges in the US.

ipo sept23 The end of the third quarter is fast approaching. The third quarter IPO activity in the U.S. pharma/biotech sector has had a strong showing, with 30 listings so far for the period.

goodsrx sept22 Santa Monica-based GoodRx Holdings, which operates a digital platform for consumer healthcare products and services, is scheduled to make its debut on the Nasdaq Global Select Market under the symbol "GDRX" on September 23, 2020.

tayshagenetherapies sept21 Dallas, Texas-based Taysha Gene Therapies is scheduled to make its debut on the Nasdaq Global Select Market under the symbol "TSHA" on September 24, 2020. Taysha Gene Therapies is a patient-centric gene therapy company developing AAV-based gene therapies for the treatment of monogenic diseases of the central nervous system.

mersana sept17 Shares of Mersana Therapeutics Inc. (MRSN), which closed at an all-time high of $25.70 yesterday, have gained an impressive 340 percent year-to-date, thanks to positive developments related to its clinical programs.

dyne sept16 In the healthcare sector, two companies made their stock market debut in the first half of this month.

Follow RTT